Green J A, Dawson A A, Fell L F, Murray S
Br J Clin Pharmacol. 1980 May;9(5):511-4. doi: 10.1111/j.1365-2125.1980.tb05847.x.
The dose of combination chemotherapy in Hodgkin's disease is commonly calculated from a formula based on the body surface area. A method is described for measuring the intensity of combination chemotherapy actually received compared to the calculated planned dose. The technique is applied to 56 patients receiving mustine, vinblastine, procarbazine and prednisolone, but would also be suitable for other cytotoxic regimens. The planned dosage intensity had to be significantly reduced in over half of the patients because of marrow toxicity. Splenectomized patients received a higher dose intensity than those in whom the procedure was not performed.
霍奇金病联合化疗的剂量通常根据基于体表面积的公式来计算。本文描述了一种方法，用于测量实际接受的联合化疗强度与计算出的计划剂量相比的情况。该技术应用于56例接受氮芥、长春花碱、丙卡巴肼和泼尼松龙治疗的患者，但也适用于其他细胞毒性治疗方案。由于骨髓毒性，超过半数的患者不得不显著降低计划的剂量强度。脾切除患者比未进行该手术的患者接受了更高的剂量强度。
